Magle Chemoswed Holding AB (publ)

kr 0.28As of Sun 8 Nov 2026, 12:00 UTC
STO:MAGLEHealthcare
Country Sweden
PE (Fwd) •••
TSR 6Y CAGR (48.94%)
Div yield —
ROE (66.30%)
Biotechnology
Beta (5Y) 0.40
PE TTM —
TSR TTM (98.53%)
Mkt cap kr 8.474M
ROIC (21.44%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.287
2.47%
(33.32%)
Buy 6|4|9|3|0
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
—
0.01
0.01
0.01
24.39%
33.66%
39.91%
22.26%
Revenuekr M
0.547
0.580
0.602
0.591
5.11%
9.89%
9.80%
5.45%
Peers (US$0.857M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
4.185
(0.027)
(0.028)
EBIT/Intx
0.891
0.120
0.126
Own earn%
10.88
88.44
99.20
Sh yield%
15.41
39.48
39.55
Owners
Insiders/Inst%
5.21
40.80
Short interest%
4.08
SBC / revenue%
2.32
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
23–26
$1 testx
—
Incr. ROIC%
16